0.00Open4.20Pre Close0 Volume1 Open Interest16.50Strike Price0.00Turnover707.90%IV33.66%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry4.20Extrinsic Value100Contract SizeAmericanOptions Type-0.3007Delta0.0252Gamma4.41Leverage Ratio-0.6302Theta-0.0010Rho-1.33Eff Leverage0.0068Vega
Summit Therapeutics Stock Discussion
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet